VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
MOHMolina Healthcare, Inc.
$195.37$10.2B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. MOH
  3. Financial Ratios

Molina Healthcare, Inc. (MOH) Financial Ratios

24 years of historical data (2002–2025) · Healthcare · Medical - Healthcare Plans

View Quarterly Ratios →

P/E Ratio
↓
21.90
+4% vs avg
5yr avg: 21.12
055%ile100
30Y Low7.8·High128.9
View P/E History →
EV/EBITDA
↓
10.12
-8% vs avg
5yr avg: 10.99
082%ile100
30Y Low2.0·High14.4
P/FCF
↑
N/A
—
5yr avg: 20.41
30Y Low2.7·High85.2
P/B Ratio
↓
2.44
↓-50% vs avg
5yr avg: 4.90
052%ile100
30Y Low0.9·High7.1
ROE
↓
11.0%
↑-56% vs avg
5yr avg: 24.9%
042%ile100
30Y Low-34%·High47%
Debt/EBITDA
↑
4.05
↑+85% vs avg
5yr avg: 2.18
0100%ile100
30Y Low0.0·High4.0

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

MOH Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

Molina Healthcare, Inc. trades at 21.9x earnings, roughly in line with its 5-year average of 21.1x, sitting at the 55th percentile of its historical range. This is roughly in line with the Healthcare sector median P/E of 22.1x.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$10.2B$8.8B$16.8B$21.0B$19.3B$18.6B$12.7B$8.7B$7.8B$4.3B$3.0B
Enterprise Value$9.9B$8.5B$15.2B$18.5B$17.7B$16.6B$10.9B$7.7B$6.4B$3.3B$1.9B
P/E Ratio →21.9019.4614.2519.2424.3928.2718.9211.8211.02—58.98
P/S Ratio0.220.190.410.620.600.670.660.520.410.220.17
P/B Ratio2.442.173.744.986.527.096.084.444.733.211.84
P/FCF——30.8713.3028.339.137.0223.54—5.986.11
P/OCF——26.0812.6324.998.806.7420.40—5.344.51

P/E links to full P/E history page with 30-year chart

MOH EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

Molina Healthcare, Inc.'s enterprise value stands at 10.1x EBITDA, 8% below its 5-year average of 11.0x. The Healthcare sector median is 14.2x, placing the stock at a 29% discount on an enterprise-value basis.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.190.380.540.550.600.560.460.340.160.11
EV / EBITDA10.128.738.0610.6213.1214.429.386.845.10—3.82
EV / EBIT12.6510.908.9311.7815.0916.6810.297.315.76—6.09
EV / FCF——28.0311.7425.968.136.0220.93—4.563.75

MOH Profitability

Margins and return-on-capital ratios measuring operating efficiency

Molina Healthcare, Inc. earns an operating margin of 1.7%. Operating margins have compressed from 4.6% to 1.7% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROE of 11.0% is modest. ROIC of 17.4% represents solid returns on invested capital.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin9.0%9.0%11.7%12.7%12.3%11.8%13.8%14.5%13.9%9.5%10.0%
Operating Margin1.7%1.7%4.2%4.6%3.7%3.7%5.6%6.2%6.0%-2.8%1.7%
Net Profit Margin1.0%1.0%2.9%3.2%2.5%2.4%3.5%4.4%3.7%-2.6%0.0%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE11.0%11.0%27.1%30.4%28.3%27.9%33.2%40.9%47.4%-34.3%0.5%
ROA3.0%3.0%7.7%8.0%6.5%6.1%8.2%10.6%9.0%-6.4%0.1%
ROIC17.4%17.4%54.4%76.1%91.0%174.3%125.5%123.0%283.2%-104.7%35.0%
ROCE9.8%9.8%23.6%25.8%22.1%21.0%26.7%32.5%38.9%-19.2%10.9%

MOH Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

Molina Healthcare, Inc. carries a Debt/EBITDA ratio of 4.0x, which is highly leveraged (26% above the sector average of 3.2x). The company holds a net cash position — cash of $4.2B exceeds total debt of $4.0B, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns. Interest coverage of 4.1x is adequate, though a cyclical earnings downturn could tighten the margin of safety.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.970.970.690.570.810.911.120.760.891.621.00
Debt / EBITDA4.054.051.651.371.772.082.021.311.16—3.37
Net Debt / Equity—-0.07-0.34-0.58-0.54-0.78-0.86-0.49-0.83-0.76-0.71
Net Debt / EBITDA-0.31-0.31-0.82-1.41-1.20-1.78-1.55-0.85-1.09—-2.41
Debt / FCF——-2.84-1.56-2.37-1.00-0.99-2.61—-1.42-2.36
Interest Coverage4.074.0714.4714.4310.668.2910.4212.179.69-4.193.03

Net cash position: cash ($4.2B) exceeds total debt ($4.0B)

MOH Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

A current ratio of 1.69x means Molina Healthcare, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.54x to 1.69x over the past 3 years.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio1.691.691.621.541.471.431.591.831.521.351.31
Quick Ratio1.691.691.621.541.471.431.591.831.521.351.31
Cash Ratio0.580.581.141.111.091.081.211.351.061.031.00
Asset Turnover—2.922.602.292.602.272.042.482.642.352.38
Inventory Turnover———————————
Days Sales Outstanding———————————

MOH Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Molina Healthcare, Inc. returns 9.8% to shareholders annually primarily through share buybacks. The earnings yield of 4.6% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield4.6%5.1%7.0%5.2%4.1%3.5%5.3%8.5%9.1%—1.7%
FCF Yield——3.2%7.5%3.5%11.0%14.3%4.2%—16.7%16.4%
Buyback Yield9.8%11.3%6.0%0.3%2.1%0.7%4.8%0.5%0.0%0.0%0.0%
Total Shareholder Yield9.8%11.3%6.0%0.3%2.1%0.7%4.8%0.5%0.0%0.0%0.0%
Shares Outstanding—$51M$58M$58M$59M$59M$60M$64M$67M$56M$56M

Peer Comparison

Compare MOH with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
MOH logoMOHYou$10B21.910.1—9.0%1.7%11.0%17.4%4.0
CNC logoCNC$30B-4.5—7.012.2%-3.9%-28.7%-21.6%—
ALHC logoALHC$4B-5908.193.439.512.4%0.4%-0.5%—7.5
UNH logoUNH$364B30.317.922.618.5%4.2%11.8%9.2%3.4
CVS logoCVS$125B70.714.016.113.8%2.6%2.3%5.0%6.2
ELV logoELV$84B15.511.226.625.6%4.1%13.3%9.1%3.4
HUM logoHUM$43B36.722.9115.514.5%1.1%7.0%4.1%5.7
CI logoCI$74B12.68.38.89.5%3.3%14.3%10.4%2.7
OSCR logoOSCR$7B-16.8—7.014.4%-3.4%-44.4%——
MCK logoMCK$90B19.613.215.83.6%1.6%—254.1%1.2
CAH logoCAH$52B34.418.828.23.7%1.0%—3378.7%3.0
Healthcare Median—22.114.218.563.9%-4.3%-32.6%-11.6%3.2

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 24 years · Updated daily

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into MOH consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MOH — Frequently Asked Questions

Quick answers to the most common questions about buying MOH stock.

What is Molina Healthcare, Inc.'s P/E ratio?

Molina Healthcare, Inc.'s current P/E ratio is 21.9x. The historical average is 28.4x. This places it at the 55th percentile of its historical range.

What is Molina Healthcare, Inc.'s EV/EBITDA?

Molina Healthcare, Inc.'s current EV/EBITDA is 10.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 7.0x.

What is Molina Healthcare, Inc.'s ROE?

Molina Healthcare, Inc.'s return on equity (ROE) is 11.0%. The historical average is 15.8%.

Is MOH stock overvalued?

Based on historical data, Molina Healthcare, Inc. is trading at a P/E of 21.9x. This is at the 55th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Molina Healthcare, Inc.'s profit margins?

Molina Healthcare, Inc. has 9.0% gross margin and 1.7% operating margin.

How much debt does Molina Healthcare, Inc. have?

Molina Healthcare, Inc.'s Debt/EBITDA ratio is 4.0x, indicating high leverage. A ratio above 4x may signal elevated financial risk.